Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

differentiation syndrome

(DIH-feh-REN-shee-AY-shun SIN-drome)
A serious side effect that may occur in patients with acute promyelocytic leukemia or other types of acute myeloid leukemia who have been treated with certain types of anticancer drugs. Differentiation syndrome usually occurs within 1 to 2 weeks after starting treatment, but it can occur later. It is caused by a large, rapid release of cytokines (immune substances) from leukemia cells that are affected by the anticancer drugs. Signs and symptoms of differentiation syndrome include fever; cough; trouble breathing; weight gain; swelling of the arms, legs, and neck; build-up of excess fluid around the heart and lungs; low blood pressure; and kidney failure. Differentiation syndrome can be life-threatening if not treated early.
Search NCI's Dictionary of Cancer Terms